<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Gilead Presents 96-week Discover Trial Data Supporting Non-inferior Efficacy and Key Safety Differences of Descovy For PrEP™ Compared With Truvada For PrEP®	</title>
	<atom:link href="https://www.novumpr.nl/2019/11/06/gilead-presents-96-week-discover-trial-data-supporting-non-inferior-efficacy-and-key-safety-differences-of-descovy-for-prep-compared-with-truvada-for-prep/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.novumpr.nl/2019/11/06/gilead-presents-96-week-discover-trial-data-supporting-non-inferior-efficacy-and-key-safety-differences-of-descovy-for-prep-compared-with-truvada-for-prep/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=gilead-presents-96-week-discover-trial-data-supporting-non-inferior-efficacy-and-key-safety-differences-of-descovy-for-prep-compared-with-truvada-for-prep</link>
	<description>NovumPR press releases</description>
	<lastBuildDate>Wed, 06 Nov 2019 11:45:00 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.3</generator>
</channel>
</rss>
